Mast Therapeutics Provides Additional Results From Nonclinical Heart Failure Study - Statistically significant and durable reductions in troponin and NT-proBNP - Minimal effect on heart rate and vascular resistance - Potentially novel mechanistic approach to treatment of heart failure